Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla Ventures (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla VenturesAfter years of focusing on all things artificial intelligence, the buzziest buzz in medtech now centers not on robots and algorithms
Click here to read full news..

guestpostbloggingwork

myworldmarkstory

synchron series khosla venturesparkfiercebiotech,synchron khosla venturesparkfiercebiotech